LPA1 Inhibition Induces Metastatic Dormancy In Mouse Models Of Breast Cancer
 

A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to a study published August 21 in the Journal of the National Cancer Institute. Metastasis is a main contributor to mortality in cancer patients...

More...